VCEL Price / Book | VERICEL CORPORATION

VERICEL CORPORATION (VCEL) Price / Book

2026-09-03: Price/Book Ratio 5.6.
2026-06-30: Price/Book Ratio 6.15.
2026-03-31: Price/Book Ratio 4.61.
2025-12-31: Price/Book Ratio 5.14.

Historical market capitalization divided by filed shareholder equity.

Available history: 2010-12-31 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	5.6
2026-06-30	6.15
2026-03-31	4.61
2025-12-31	5.14
2025-09-30	4.94
2025-06-30	7
2025-03-31	7.59
2024-12-31	9.33
2024-09-30	8.08
2024-06-30	9.23
2024-03-31	10.78
2023-12-31	7.54
2023-09-30	7.82
2023-06-30	8.99
2023-03-31	7.18
2022-12-31	6.47
2022-09-30	6.16
2022-06-30	6.79
2022-03-31	10.43
2021-12-31	10.81
2021-09-30	14.56
2021-06-30	16.18
2021-03-31	18.31
2020-12-31	10.53
2020-09-30	7.33
2020-06-30	5.8
2020-03-31	3.73
2019-12-31	7.03
2019-09-30	6.95
2019-06-30	9.4
2019-03-31	7.45
2018-12-31	7.42
2018-09-30	6.47
2018-06-30	4.57
2018-03-31	17.35
2017-12-31	8.67
2017-09-30	12.49
2017-06-30	7.74
2017-03-31	5.91
2016-12-31	3.84
2016-09-30	5.85
2016-06-30	3.13
2016-03-31	7.25
2015-12-31	2.77
2015-09-30	2.44
2015-06-30	2.81
2015-03-31	2.78
2014-12-31	2.03
2014-09-30	1.79
2014-06-30	10.33
2014-03-31	7.27
2013-12-31	3.92
2013-09-30	97.79
2010-12-31	676.64

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
RECURSION PHARMACEUTICALS, INC. (RXRX)	United States	$2.080B	-3.78
Kodiak Sciences Inc. (KOD)	United States	$2.090B	-10.12
ADMA BIOLOGICS, INC. (ADMA)	United States	$2.131B	11.16
BIOCRYST PHARMACEUTICALS INC (BCRX)	United States	$2.175B	-6.63
Vir Biotechnology, Inc. (VIR)	United States	$1.814B	-6.85
NOVAVAX INC (NVAX)	United States	$1.748B	-6.26
Hemab Therapeutics Holdings, Inc. (COAG)	United States	$1.672B
Greenland Mines Ltd (GRML)	United States	$2.362B
Immunocore Holdings plc (IMCR)		$1.613B	-90.43
Taysha Gene Therapies, Inc. (TSHA)	United States	$1.564B	-14.80